All these indicated that HOTAIR and its genetic variations may be a potential biomarker for risk assessment, early detection and therapeutic target of gastric cancer; and larger prospective and experimental studies were warranted to further validation. The gene discussed is HOTAIR; the disease is gastric cancer.